• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人P2Y4受体的药理学特性

Pharmacological characterization of the human P2Y4 receptor.

作者信息

Communi D, Motte S, Boeynaems J M, Pirotton S

机构信息

Institute of Interdisciplinary Research, School of Medicine, Erasme Hospital, Université Libre de Bruxelles, Belgium.

出版信息

Eur J Pharmacol. 1996 Dec 19;317(2-3):383-9. doi: 10.1016/s0014-2999(96)00740-6.

DOI:10.1016/s0014-2999(96)00740-6
PMID:8997625
Abstract

The P2Y4 receptor is a new member of the P2Y family which functionally behaves as a pyrimidinergic receptor. The pharmacological properties of the human P2Y4 receptor have been characterized following its stable expression in 1321N1 astrocytoma cells. UTP induced a biphasic accumulation of inositol trisphosphates, with an early peak at 30 s followed by a smaller but more sustained accumulation. ATP was a pure antagonist at early times and later behaved as a partial agonist. At 20 min, the rank order of potency of various nucleotides was the following: UTP > UDP = deoxy UTP > 5-bromo-UTP > ITP > ATP. Diadenosine polyphosphates also stimulated the production of inositol trisphosphates (after 20 min), more potently than ATP, but their maximal effect represented only 20-25% of that of UTP. Pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid inhibited strongly the UTP response, whereas suramin was inactive and reactive blue 2 had an intermediate effect. Pertussis toxin inhibited the response to UTP at early times (62 +/- 5% inhibition at 30 s), but its effect was no longer observed at 5 or 20 min. It is speculated that the P2Y4 receptor can exist in two distinct activation states differing in terms of time-course, specificity for uridine nucleotides and G-protein coupling.

摘要

P2Y4受体是P2Y家族的新成员,其功能上表现为嘧啶能受体。人P2Y4受体在1321N1星形细胞瘤细胞中稳定表达后,其药理学特性已得到表征。UTP诱导肌醇三磷酸呈双相积累,30秒时出现早期峰值,随后积累量较小但更持久。ATP在早期是纯拮抗剂,后来表现为部分激动剂。在20分钟时,各种核苷酸的效力排序如下:UTP>UDP =脱氧UTP>5-溴-UTP>ITP>ATP。二腺苷多磷酸也刺激肌醇三磷酸的产生(20分钟后),比ATP更有效,但它们的最大效应仅为UTP的20-25%。磷酸吡哆醛-6-偶氮苯基-2',4'-二磺酸强烈抑制UTP反应,而苏拉明无活性,活性蓝2有中等作用。百日咳毒素在早期抑制对UTP的反应(30秒时抑制62±5%),但在5或20分钟时不再观察到其作用。据推测,P2Y4受体可以以两种不同的激活状态存在,在时间进程、对尿苷核苷酸的特异性和G蛋白偶联方面有所不同。

相似文献

1
Pharmacological characterization of the human P2Y4 receptor.人P2Y4受体的药理学特性
Eur J Pharmacol. 1996 Dec 19;317(2-3):383-9. doi: 10.1016/s0014-2999(96)00740-6.
2
Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.小鼠主动脉内皮细胞上核苷酸P2Y受体的药理学特性
Br J Pharmacol. 2005 Sep;146(2):288-95. doi: 10.1038/sj.bjp.0706326.
3
Two different P2Y receptors linked to steroidogenesis in bovine adrenocortical cells.两种不同的P2Y受体与牛肾上腺皮质细胞中的类固醇生成相关。
Jpn J Pharmacol. 1999 Oct;81(2):194-9. doi: 10.1254/jjp.81.194.
4
Slow desensitization of the human P2Y6 receptor.人P2Y6受体的缓慢脱敏
Eur J Pharmacol. 1997 Jun 25;329(2-3):231-6.
5
Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress.尿嘧啶核苷酸在保护心肌细胞免受缺氧应激中的作用。
Biochem Pharmacol. 2005 Apr 15;69(8):1215-23. doi: 10.1016/j.bcp.2005.01.018.
6
ATP and UTP responses of cultured rat aortic smooth muscle cells revisited: dominance of P2Y2 receptors.重新审视培养的大鼠主动脉平滑肌细胞的ATP和UTP反应:P2Y2受体的主导作用
Br J Pharmacol. 2003 Dec;140(7):1169-76. doi: 10.1038/sj.bjp.0705526. Epub 2003 Nov 3.
7
Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.尿嘧啶和腺嘌呤核苷酸的甲碳硼烷修饰:在P2Y1、P2Y2、P2Y4和P2Y11受体上北环构象具有高效能,但在P2Y6受体上则不然。
J Med Chem. 2002 Jan 3;45(1):208-18. doi: 10.1021/jm010369e.
8
Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP.克隆和转染的P2Y4受体:对尿苷三磷酸(UTP)的一种对苏拉明和血小板源性生长因子结合蛋白(PPADS)不敏感反应的特性
Br J Pharmacol. 1996 Dec;119(7):1301-3. doi: 10.1111/j.1476-5381.1996.tb16038.x.
9
Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions.大鼠P2Y2和大鼠P2Y4受体的扩展药理学特征及其对细胞外H⁺和Zn²⁺离子的敏感性。
Br J Pharmacol. 2003 Dec;140(7):1177-86. doi: 10.1038/sj.bjp.0705544. Epub 2003 Oct 27.
10
A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.大鼠背侧脊髓星形胶质细胞亚群表达的一种新型P2嘌呤受体。
Br J Pharmacol. 1995 Dec;116(7):2909-18. doi: 10.1111/j.1476-5381.1995.tb15944.x.

引用本文的文献

1
Uridine and uridine nucleotides as novel regulators of NUCB2/nesfatin-1 neuron activation: an immunohistochemical study.尿苷和尿苷核苷酸作为NUCB2/nesfatin-1神经元激活的新型调节剂:一项免疫组织化学研究
Histochem Cell Biol. 2025 Jul 7;163(1):73. doi: 10.1007/s00418-025-02404-2.
2
Structural insight into the self-activation and G-protein coupling of P2Y2 receptor.P2Y2受体自激活和G蛋白偶联的结构解析
Cell Discov. 2025 May 13;11(1):47. doi: 10.1038/s41421-025-00797-x.
3
Testosterone Enhances K Currents and Airway Smooth Muscle Relaxation Induced by ATP and UTP through P2Y Receptors and Adenylyl Cyclase Pathway.
睾酮通过 P2Y 受体和腺苷酸环化酶通路增强由 ATP 和 UTP 诱导的钾电流和气道平滑肌松弛。
Int J Mol Sci. 2024 Apr 24;25(9):4652. doi: 10.3390/ijms25094652.
4
Loss-of-function N178T variant of the human P2Y receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis.人类P2Y受体功能丧失性N178T变体与冠状动脉疾病严重程度降低及葡萄糖稳态改善相关。
Front Pharmacol. 2022 Dec 2;13:1049696. doi: 10.3389/fphar.2022.1049696. eCollection 2022.
5
Adipocyte purinergic receptors activated by uracil nucleotides as obesity and type 2 diabetes targets.作为肥胖和 2 型糖尿病靶点的脂肪细胞嘌呤能受体被尿嘧啶核苷酸激活。
Curr Opin Pharmacol. 2022 Apr;63:102190. doi: 10.1016/j.coph.2022.102190. Epub 2022 Feb 26.
6
An Open-Source Framework for Automated High-Throughput Cell Biology Experiments.用于自动化高通量细胞生物学实验的开源框架。
Front Cell Dev Biol. 2021 Sep 24;9:697584. doi: 10.3389/fcell.2021.697584. eCollection 2021.
7
Control of Macrophage Inflammation by P2Y Purinergic Receptors.P2Y 嘌呤能受体对巨噬细胞炎症的控制。
Cells. 2021 May 4;10(5):1098. doi: 10.3390/cells10051098.
8
From purines to purinergic signalling: molecular functions and human diseases.从嘌呤到嘌呤能信号转导:分子功能与人类疾病。
Signal Transduct Target Ther. 2021 Apr 28;6(1):162. doi: 10.1038/s41392-021-00553-z.
9
P2 Receptors in Cardiac Myocyte Pathophysiology and Mechanotransduction.心肌细胞病理生理学和机械转导中的 P2 受体。
Int J Mol Sci. 2020 Dec 29;22(1):251. doi: 10.3390/ijms22010251.
10
Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications.中枢神经系统的嘌呤能受体:生物学、PET配体及其应用。
Mol Imaging. 2020 Jan-Dec;19:1536012120927609. doi: 10.1177/1536012120927609.